Frank Eldridge Lovering

Title: Frank Eldridge Lovering: Innovator in Pharmaceutical Compounds

Introduction

Frank Eldridge Lovering is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 17 patents. His work primarily focuses on the development of innovative compounds that have therapeutic applications.

Latest Patents

Among his latest patents are those related to bicyclic-fused heteroaryl or aryl compounds. These patents disclose compounds, tautomers, and pharmaceutically acceptable salts of the compounds, which are defined by a specific structure outlined in the specifications. In one embodiment, a pharmaceutical composition can be formulated in a liquid dosage form, containing a therapeutically effective amount of the compound or its pharmaceutically acceptable salt as an adjuvant and therapeutic agent. Additionally, methods of adjuvant treating various disorders or conditions through the administration of these pharmaceutical compositions to patients are also described.

Career Highlights

Throughout his career, Frank has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Wyeth. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Frank has collaborated with several professionals in his field, including Joseph Walter Strohbach and David Hepworth. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Frank Eldridge Lovering's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant innovator. His work continues to influence the development of therapeutic compounds that can improve patient care.